Under Glenmark's 2004 collaborative deal with Forest, the latter had the right to develop and sell the asthma and chronic obstructive pulmonary disorder drug in North America for an upfront payment and additional fees for each developmental milestone that could total $190 million in all. Upon commercialisation, Glenmark will retain the rights for selling the drug for the rest of the world while Forest will continue to sell the drug in North American.
Leading IT solution provider HCL Technologies Ltd has signed an agreement with Glenmark Pharmaceuticals Ltd for implementing its comprehensive drug labeling framework
A sharp increase in interest costs has caused Glenmark Pharmaceuticals to post a consolidated net profit of Rs 80.9 crore for the second quarter, 31 percent lower than the Rs 117.3 crore for the previous corresponding quarter.
Glenmark Pharmaceuticals on Monday announced its Swiss subsidiary has completed phase I clinical trials for GRC 6211, a pain reliever, and plans to launch the molecule in 2011.
India, with 22 entries, is fourth in terms of the number of the companies included in the list, which is led by Greater China outperforming the others in the Asia-Pacific region with 88 entries followed by Taiwan and Japan with 24 and 23 firms, respectively. The annual 'Best Under a Billion' list picks the best 200 small and medium sized companies from 24,155 listed firms in the Asia-Pacific region.
The domestic pharmaceuticals industry has proven its mettle once again with Glenmark Pharmaceuticals announcing the receipt of euro 25 million from German drug major Merck
Pharmaceutical firm Glenmark said on Monday it had signed a supply and marketing agreement with Aspen USA for joint manufacturing and sales of three generic products in US.
Glenmark Holdings SA, a wholly-owned Swiss subsidiary of Glenmark Pharmaceuticals, has signed a deal to acquire majority shareholding (less than 90 per cent) of Czech firm Medicamenta.
Glenmark Pharmaceuticals has entered into an agreement with Shasun for joint development, filing and marketing of 12 generic drugs for the US market.
In a bid to tap the potential in Latin America, Glenmark Pharmaceuticals Ltd has acquired Brazil-based Laboratorios Klinger, ranked among the top 50 in that country, for $5.2 million.\n\n\n\n
Glenmark Pharmaceuticals Ltd has set up a wholly-owned subsidiary in the US to step up presence for the company's formulations and Active Pharmaceuticals Ingredients in that market.
In a bid to tap overseas market, Glenmark Pharmaceuticals Ltd's wholly owned US subsidiary has entered into a product development and marketing licence agreement with US-based K V Pharmaceutical Company
According to analysts, Glenmark will have to pay a penalty of $16 million, following the latest verdict.
Ajit Mishra, vice president, Research, Religare Broking, answers your stock market queries.
.jpg)
Global pharmaceutical firms have had a series of patent disputes with Indian makers of generic drugs and several recent Indian rulings have gone against the international giants.
Riluzole is indicated for the treatment of amyotrophic lateral sclerosis.
The Central Bureau of Investigation on Thursday night arrested a Mumbai-based chartered accountant and two government officials for allegedly selling confidential documents related to foreign investment policy to corporate groups after it carried out searches in offices of Finance and Commerce Ministries in New Delhi and in Mumbai.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Other Health Food Drinks brands of GSK -- Boost, Maltova and Viva -- would come to HUL's portfolio by virtue of the merger, making it a leading player in the segment.
Rosier year-end seen for Indian pharma thanks to faster US approvals.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Sensex, Nifty end the day in red on unfavourable cues from global markets.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
The private companies announced projects worth Rs 11.33 lakh crore (Rs 11.33 trillion) during 2014-16.
In the broader market, the S&P BSE Midcap added over 1% to finish at record closing high
As the death toll in the country from coronavirus jumped by a record 445 to 13,699, the Centre maintained that the number of infections per lakh population was among the lowest in the world. The new cases surged by over 10,000 for the 11th day in a row and rose by 14,821 to take the total to 4,25,282, according to health ministry data.
6 locations in New Delhi and 2 in Mumbai were raided.
Bharti Airtel , RCom and Tata Communications ended down between 0.1-1%.
Rate sensitive sectors were among the top gainers with Tata Motors and ICICI Bank leading the gains on the Sensex.
Some Indian generic drugmakers are, however, uncertain about the pace of approvals in the near future.
Asia's falling stocks have triggered an exodus of funds from the region.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances